• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ovid Therapeutics Inc. - Common Stock (NQ:OVID)

1.780 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 67
Open 1.780
Bid (Size) 1.760 (500)
Ask (Size) 1.800 (300)
Prev. Close 1.780
Today's Range 1.780 - 1.780
52wk Range 0.2425 - 2.010
Shares Outstanding 70,417,345
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
December 18, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
December 02, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire

Performance

YTD
+1.1%
+1.1%
1 Month
+12.7%
+12.7%
3 Month
+12.7%
+12.7%
6 Month
+307.0%
+307.0%
1 Year
+84.8%
+84.8%

More News

Read More
News headline image
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
November 17, 2025
Via Benzinga
News headline image
OVID THERAPEUTICS INC (NASDAQ:OVID) Announces Leadership Transition and Key Pipeline Milestones Following Q3 2025 Results ↗
November 12, 2025
Via Chartmill
News headline image
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results
November 12, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
October 03, 2025
Via Chartmill
News headline image
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why ↗
October 03, 2025
Via Stocktwits
Topics Intellectual Property
News headline image
These stocks that are showing activity before the opening bell on Friday. ↗
October 03, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
October 03, 2025
Via Benzinga
News headline image
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
October 03, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
October 03, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗
September 02, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
August 13, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
August 13, 2025
Via Benzinga
News headline image
Top movers in Wednesday's session ↗
August 13, 2025
Via Chartmill
News headline image
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
August 13, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
July 23, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Which stocks are moving after the closing bell on Tuesday? ↗
July 22, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
July 21, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
July 17, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
June 27, 2025
Via Benzinga
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
June 27, 2025
Via Chartmill
News headline image
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
June 05, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
May 13, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Ovid Therapeutics Inc. - Common Stock publicly traded?
Yes, Ovid Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Ovid Therapeutics Inc. - Common Stock trade on?
Ovid Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ovid Therapeutics Inc. - Common Stock?
The ticker symbol for Ovid Therapeutics Inc. - Common Stock is OVID on the Nasdaq Stock Market
What is the current price of Ovid Therapeutics Inc. - Common Stock?
The current price of Ovid Therapeutics Inc. - Common Stock is 1.780
When was Ovid Therapeutics Inc. - Common Stock last traded?
The last trade of Ovid Therapeutics Inc. - Common Stock was at 01/07/26 04:00 PM ET
What is the market capitalization of Ovid Therapeutics Inc. - Common Stock?
The market capitalization of Ovid Therapeutics Inc. - Common Stock is 125.34M
How many shares of Ovid Therapeutics Inc. - Common Stock are outstanding?
Ovid Therapeutics Inc. - Common Stock has 125M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap